Morgan Stanley MD Promotions Buck Wall Street Trend to Go Big
At Morgan Stanley, 2024 marked Ted Pick’s first full year at the helm of the firm and the restrained size of its new MDs likely reflects his desire to keep the firm’s top rank a little more selective even as he contends with industrywide pressure to retain moneymakers across its ranks.
Morgan Stanley has upgraded Gilead Sciences (NASDAQ:GILD) to overweight from equal weight, citing the company's HIV drug ...
Vir Biotechnology's Phase 1 data highlights early promise for T-cell engagers targeting HER2-positive tumors and prostate ...
The popularity of alcohol-free Guinness won’t protect the shares of its owner Diageo Plc from the growing trend toward health ...
Jim Caron of Morgan Stanley Investment Management explains what's behind the steepening yield curve and what it's telling us ...
Among 26 home price forecast models tracked by ResiClub, Morgan Stanley is the most bearish on the 2025 housing market.
Morgan Stanley Mortgage Capital Holdings has scheduled a foreclosure auction for the 2.2M SF office park near the ...
Morgan Stanley on Thursday announced its departure from a coalition of banks that aims to target net-zero emissions through ...
Morgan Stanley is a buy on weakness with strong dividend growth and projected revenue growth in Q4 2024 and early 2025. Click for our MS earnings preview.
Markets 2024-12-28T10:00:01Z Morgan Stanley CIO Mike Wilson warns the S&P 500 faces a decade of 'flat-ish' returns ahead — but shares 2 investments with high odds of making you 'pretty good ...
Morgan Stanley closed $12.79 short of its 52-week high ($136.24), which the company achieved on November 25th.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback